Understanding melanocortin-4 receptor control of neuronal circuits: toward novel therapeutics for obesity syndrome
To view or add a comment, sign in Latest News : "Sultiame Reduces Apnoea Events in Phase 2 FLOW Trial" The phase 2 FLOW trial shows sultiame caused consistent, dose-dependent improvements in obstructive sleep apnoea, nocturnal hypoxia, and sleep quality, highlighting its potential as a pharmacological treatment
Its very exciting a really interesting new area for pharmacists to consider, and an important continuous-learning opportunity for pharmacists and pharmacy students
Glutathione synthesis contributes to virulence of streptococcus agalactiae in a murine model of sepsis
They can give you specific advice based on your medical history, current medications, and lifestyle
Exendin is a peptide-1 receptor agonist protein typically found and produced in the gut of desert-dwelling reptiles[12]